ATTRPod Podcast Evaluation

Course Title for Certificate

Name

First NameLast Name

Email

example@example.com

What best describes your title?

How many years have you been in practice?

1. Which of the following laboratory tests are recommended in screening for AL amyloidosis?

2. The most common hereditary transthyretin variant in the United States is:

3. Which of the following is approved for the treatment of transthyretin amyloid cardiomyopathy in the United States?

4. Which of the below treatments increases serum transthyretin levels?

How many patients do you currently see each month regarding transthyretin amyloidosis?

Learning Objectives

Rows	Poor	Fair	Good	Very Good	Excellent
Review the genetics and pathogenesis of ATTR-CM, as well as existing treatment guidelines (US and European) and how those factors inform approaches to patient identification and recognition of heart failure risk
Analyze clinical trial data presented at ACC2025 for the treatment of patients with ATTR-CM
Evaluate practical strategies to incorporate new data into current and future practice in the management of individuals with ATTR-CM

Please provide us with feedback regarding your experience at the activity:

Do you feel this activity was fair, balanced, and free of commercial bias?

If no, please explain:

This educational activity will result in a change in my role as a healthcare team member.

Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:

What factors beyond clinical care that effect the health of your patients does your team experience?

Attestation:

AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits^TM.

Date

Credits